Reposted by Kris Wernowsky
These suits are in addition to Louisiana's case against the FDA They try to buttress the state's claim that ending telehealth of mifepristone will end medication abortions in ban states. That's because, SG Benjamin Aguiñaga claims, the suit against providers would also ban misoprostol-only abortions
autonomynews.co
FDA Lawyer Leaves Door Wide Open for Mifepristone Restrictions at Appeals Court Hearing
Louisiana made misleading claims about the safety of medication abortion, while the Justice Department sidestepped questions about whether the drug should remain available via telehealth.